Humana (HUM) Free Cash Flow (2009 - 2026)

Humana (HUM) has reported Free Cash Flow for 18 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 58.51% year-over-year to $1.8 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 20.09% decrease from a year earlier, with the FY2025 full-year figure at $375.0 million, down 84.32% from the prior year.
• Free Cash Flow was $1.8 billion for Q2 2026 at Humana, up from $1.1 billion in the prior quarter.
• Over five years, Free Cash Flow peaked at $8.2 billion in Q3 2022 and troughed at -$7.4 billion in Q4 2023.
• A 5-year average of $675.6 million and a median of $927.0 million in 2023 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow slumped 995.74% in 2022 and jumped 92242.86% in 2023, its largest moves.
• Over 5 years, Free Cash Flow stood at -$5.4 billion in 2022, then plunged by 37.3% to -$7.4 billion in 2023, then soared by 90.8% to -$682.0 million in 2024, then slumped by 171.85% to -$1.9 billion in 2025, then soared by 198.92% to $1.8 billion in 2026.
• The last three Free Cash Flow figures came in at $1.8 billion (Q2 2026), $1.1 billion (Q1 2026), and -$1.9 billion (Q4 2025), per Business Quant data.